Dulaglutide – May 2022

• Brand names:
  • Trulicity®
• Pharmaceutical Company:
  • Eli Lilly Australia Pty Ltd
• Condition/Indication: Type 2 diabetes mellitus
• Meeting Date: May 2022
• Public Summary Document (PSD) May 2022 PBAC Meeting - (PDF 530KB)
• Public Summary Document (PSD) May 2022 PBAC Meeting - (Word 72KB)

Related Public Summary Documents

• Dulaglutide – March 2022